Ted Karkus's Insider Trades & SAST Disclosures
Ted Karkus's most recent trade in ProPhase Labs Inc was a trade of 400,000 Option (right to buy) done . Disclosure was reported to the exchange on March 17, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ted Karkus.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2024 | 400,000 | 400,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2024 | 400,000 | 400,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2023 | 50,000 | 3,433,750 (29%) | 0% | 0 | Common Stock, par value $0.005 | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Apr 2023 | 50,000 | 150,000 (1%) | 0% | 0 | Common Stock, par value $0.005 | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 500,000 | 500,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Apr 2023 | 100,000 | 3,483,750 (30%) | 0% | 0 | Common Stock, par value $0.005 | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 500,000 | 0 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Feb 2023 | 500,000 | 3,852,087 (33%) | 4% | 0.6 | 300,000 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.18 per share. | 01 Feb 2023 | 268,337 | 3,583,750 (30%) | 2% | 8.2 | 2,194,997 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 600,000 | 500,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 13 Jan 2023 | 600,000 | 3,671,318 (31%) | 5% | 0.6 | 360,000 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.36 per share. | 13 Jan 2023 | 319,231 | 3,352,087 (28%) | 2% | 9.4 | 2,988,002 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 16 Oct 2022 | 600,000 | 3,388,609 (29%) | 5% | 0.6 | 360,000 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2022 | 600,000 | 1,100,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.41 per share. | 16 Oct 2022 | 317,291 | 3,071,318 (26%) | 2% | 10.4 | 3,302,999 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2022 | 600,000 | 1,700,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 10 Aug 2022 | 600,000 | 3,105,214 (26%) | 5% | 0.6 | 360,000 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.84 per share. | 10 Aug 2022 | 316,605 | 2,788,609 (24%) | 2% | 10.8 | 3,431,998 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 450,000 | 0 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 23 May 2022 | 450,000 | 2,783,471 (24%) | 3% | 2 | 900,000 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.47 per share. | 23 May 2022 | 278,257 | 2,505,214 (21%) | 2% | 8.5 | 2,356,837 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.06 per share. | 03 Jun 2021 | 33,943 | 2,333,471 (20%) | 0% | 5.1 | 171,921 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2021 | 120,000 | 2,299,528 (19%) | 1% | 0 | Common Stock, par value $0.005 | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2021 | 60,000 | 100,000 (0%) | 0% | 0 | Common Stock, par value $0.005 | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.75 per share. | 13 Aug 2020 | 50,000 | 2,419,528 (20%) | 0% | 2.8 | 137,500 | Common Stock, par value $0.005 |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2020 | 54,150 | 2,469,528 (21%) | 0% | 0 | Common Stock, par value $0.005 | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2020 | 28,600 | 40,000 (0%) | 0% | 0 | Common Stock, par value $0.005 | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2020 | 25,550 | 40,000 (0%) | 0% | 0 | Common Stock, par value $0.005 | |
| ProPhase Labs Inc | Ted Karkus | Director, CEO & CHAIRMAN, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 26 Mar 2020 | 100,000 | 2,549,528 (22%) | 0% | 1.8 | 175,000 | Common Stock, par value $0.005 |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges